OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.
In this episode of OncTimes Talk , Dr. Susan MacDonald interviews Dr. Barbara Levy about the evolution of breast cancer screening. Together, they discuss balancing early detection with overtesting, empowering patients to advocate for themselves, and designing healthcare systems that put people first.
In this episode, we explore how Lytix Biopharma is advancing a new kind of cancer treatment designed to both destroy tumors and train the immune system to fight back. Dr. Øystein Rekdal joins Dr. Susan McDonald to discuss the science behind LTX-315, a first-in-class oncolytic peptide, and its ability to trigger systemic immune responses even in heavily pretreated patients. From late-stage melanoma…
In this episode, Kathryn Schmitz, PhD, MPH, explains why movement should be treated like medicine for patients with cancer. In conversation with Susan MacDonald, MD, she breaks down the evidence, addresses common barriers, and offers practical guidance for both clinicians and patients. Resources mentioned in the podcast: Moving Through Cancer: An Exercise and Strength-Training Program for the…
In this episode of Oncology Times , Dr. Susan MacDonald speaks with epidemiologist Dr. Mary Beth Terry about the alarming rise in early-onset cancers, particularly among women, and the role of environmental and lifestyle factors. They explore emerging evidence on alcohol use, plastics, vaping, and other exposures. Resources: Top 10 Tips for Healthier Home : General guidance on reducing exposures…
In this episode of OncTimes Talk , host Dr. McDonald speaks with Rose Gerber, Director of Patient Advocacy and Education at the Community Oncology Alliance (COA) and a 23‑year breast cancer survivor. Rose shares her powerful personal cancer journey and how that experience ignited her lifelong commitment to patient advocacy. She discusses the essential role of community oncology practices, the…
What happens when you survive a disaster that steals the lives of thousands of children? For Dr. Yan Leyfman, surviving Chernobyl as a child wasn't just fate—it became the foundation of a lifelong mission to heal. In this deeply personal conversation, Yan shares how tragedy shaped his calling in oncology, why empathy is the strongest medicine, and how innovation must not only save lives—but reach…
In this podcast episode, Dr. Christine Ibilibor meets with Dr. Jean-Paul De La O, a Senior Principal Medical Affairs Director at Exact Sciences, to talk about how comprehensive DNA and RNA sequencing of tumors has become easier, faster and more actionable for oncologists. The pair also discuss Exact Sciences' retrospective analysis of over 10,000 solid tumor samples profiled with the OncoExTra®…
In this episode of OncTimes Talk, we chat with Dr. Eliot Siegel, MD, FACR, FSIM, DABR; Dr. Michael Morris, MD, MS, DABR, DABNM, DCI; Dr. Babak Saboury, MD, MPH, DABR, DABNM; and Chief Medical Officer Dr. Munir Ghesani, MD, FACNM, FACR, FSNMMI from United Theranostics, a national leader in precision cancer care and radiopharmaceutical therapy. Together, these visionary physicians are advancing the…